Peter Fasse prosecutes patents and counsels clients regarding wide-ranging technologies, with an emphasis on biotechnology, healthcare, medical devices, and other biological and medical fields, as well as various green technologies.
Peter helps clients from startups to multinationals develop competitive worldwide patent strategies and establish solid and defensible patent portfolios. He performs competitive patent analyses, identifies third-party patent risks, and provides patentability and freedom to operate opinions. Peter also has experience in opposing and defending patents before the European Patent Office and in U.S. litigation and post-grant proceedings.
With especially broad technical knowledge and experience, Peter is a go-to lawyer for medical therapeutics and diagnostics devices, and imaging, microfluidic systems, liquid biopsy, cell culturing and bioprocessing, molecular biology, complex biomedical systems, optics, machine tools, lasers, and all types of green technologies.
In litigation and European opposition matters, Peter has represented clients in a variety of patent infringement suits and trade secret misappropriation cases. Specific subject matter has included:
RNAi and CRISPR therapeutics
Engineered AAV systems
Microfluidic analysis of circulating tumor and fetal cells
Cell-free DNA analysis
Next generation sequence analysis
CO2 laser systems
3D printing, e.g., of tissues, human and bacterial genes and polypeptides
Dendritic cell- and DNA- based vaccines
Nanoparticle and vector-based delivery of therapeutic agents including AAV delivery of DNA to eye and ear tissues
Automated blood analysis systems
Nucleic acid probes
Laser ablation devices
Cellulose processing for ethanol production
CO2 recycling power plants
Implantable drug delivery devices and microcapsules
Wind and solar power
Cytokines such as IL-8 and PF4, and diagnostic and therapeutic methods for, e.g., AIDS, cancer, autism, diabetes, psoriasis, and arthritis
Recognized among the “The World’s Leading Patent Practitioners” by IAM Patent 1000(2018-2022), Peter brings uncommon insight and experience in helping clients secure patents, maximize their value, and build out their IP portfolios. He has written extensively on patent-related topics and was a patent examiner at the U.S. Patent and Trademark Office before joining the firm.